The Journal of Pediatrics
Volume 132, Issue 5 , Pages 777-782 , May 1998

Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: Results of a Canadian collaborative study

Received 13 May 1997 ,Revised 10 September 1997 ,Accepted 18 September 1997.

References 

  1. Kaplan BS, Cleary TG, Obrig TG. Recent advances in understanding the patho genesis of the hemolytic uremic syndrome. Pediatr Nephrol. 1990;4:276–283
  2. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev. 1991;13:60–98
  3. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985;151:775–782
  4. Lopez EL, Diaz M, Grinstein S, Devoto S, Mendilaharzu F, Murray B, et al.  Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis. 1989;160:469–475
  5. Bitzan M, Moebius E, Ludwig K, Muller-Wiefel DE, Heesemann J, Karch H. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr. 1991;119:380–385
  6. Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM. Serologic identification of Escherichia coli O157.H7 infection in haemolytic uraemic syndrome. Lancet. 1991;337:138–140
  7. Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN, the CPKDRC Co-Investigators . A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. Epidemiol Infect. 1993;110:1–7
  8. Grandsen WR, Damm MAS, Anderson JD, Carter JE, Lior H. Further evidence associating hemolytic uremic syndrome with infection by verotoxin-producing Escherichia coli O157:H7. J Infect Dis. 1986;154:522–524
  9. Pai CH, Ahmed N, Lior H, Johnson WM, Sims HV, Woods DE. Epide miology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two year prospective study. J Infect Dis. 1988;157:1054–1057
  10. Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157:H7 in Washington State: the first year of statewide surveillance. JAMA. 1989;262:355–359
  11. Rowe PC, Walop W, Lior H, MacKenzie AM. Haemolytic uraemic syndrome after childhood Escherichia coli O157.H7 infection: are females at increased risk?. Epidemiol Infect. 1991;106:523–530
  12. Spika JS, Parsons JE, Nordenberg D, Wells JG, Gunn RA, Blake PA. Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center. J Pediatr. 1986;109:287–291
  13. Duncan L, Mai V, Carter A, Carlson JAK, Borczyk A, Karmali MA. Outbreak of gastrointestinal disease in Sarnia, Ontario. Ontario Dis Sur veillance Rep. 1986;7:604–611
  14. Belongia EA, MacDonald KL, Parham GL, White KE, Korlath JA, Lobato MN, et al.  An outbreak of Escherichia coli O157:H7 colitis associated with consumption of precooked meat patties. J Infect Dis. 1991;164:338–343
  15. Pavia AT, Nichols CR, Green DP, Tauxe RV, Mottice S, Greene KD, et al.  Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr. 1990;116:544–551
  16. Rowe PC, Orrbine E, Ogborn M, Wells GA, Winther W, Lior H, et al.  Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic uremic syndrome in a Canadian Inuit community: intestinal illness in family members as a risk factor. J Pediatr. 1994;124:21–26
  17. Bell BP, Goldoft M, Griffin PM, Davis MA, Gordon DC, Tarr PI, et al.  A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: the Washington experience. JAMA. 1994;272:1349–1353
  18. Dolislager D, Tune B. The hemolytic uremic syndrome: spectrum of severity and significance of prodrome. Am J Dis Child. 1978;132:55–58
  19. Neill MA, Christie DL, Tarr PI, Clausen CR. Subclinical hemolytic uremic syndrome in cases of hemorrhagic colitis with E. coli O157:H7. In: Abstract from International workshop and symposium on verocytotoxin- (Shiga-like toxin) producing Escherichia coli infections, Toronto. July 1987;
  20. McLaine PN, Orrbine E, Rowe PC. Childhood hemolytic uremic syndrome in Canada: a multicentre study. In:  Kaplan BS,  Trompeter RS,  Moake JL editor. Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. New York: Marcel Dekker; 1992;p. 61–71
  21. Lopez EL, Contrini MM, Devoto S, De Rose MF, Grana MG, Aversa L, et al.  Incomplete hemolytic-uremic syndrome in Argentinean children with bloody diarrhea. J Pediatr. 1995;127:364–367
  22. Rowe PC, Orrbine E, Wells GA, McLaine PN. The epidemiology of hemolytic uremic syndrome in Canadian children, 1986-1988. J Pediatr. 1991;119:218–224
  23. March SB, Ratnam S. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol. 1986;23:869–872
  24. Bitzan M, Karch H. Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome. J Clin Microbiol. 1992;30:1174–1178
  25. Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin-producing Escherichia coli in stools. Lancet. 1983;1:619–620
  26. Wells JG, Davis BR, Wachsmuth IK, Riley LW, Remis RS, Sokolow R, et al.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol. 1983;18:512–520
  27. Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis. 1990;162:553–556
  28. Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA. 1993;269:883–888
  29. Thomas A, Chart H, Cheasty T, Smith HR, Frost JA, Rowe B. Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in the United Kingdom: 1989-91. Epidemiol Infect. 1993;110:591–600
  30. Caprioli A, Luzzi I, Rosmini F, Resti C, Edefonti A, Perfumo F, et al.  Community wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis. 1994;169:208–211

☆ From the Canadian Pediatric Kidney Disease Research Center, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada; and Johns Hopkins Hospital, Baltimore, Maryland.

☆☆ Supported by a grant (6606-4519-54) from the National Health Research and Development Program, Health and Welfare Canada and in part by a Career Scientist Award to Dr. Rowe from the Ministry of Health of Ontario. Funding for the Canadian Pediatric Kidney Disease Research Centre was provided by the Foundation of the Children's Hospital of Eastern Ontario.

★ Reprint requests: Canadian Pediatric Kidney Disease Research Center, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Rd., Ottawa, Ontario, Canada K1H 8L1.

★★ 9/21/86312

PII: S0022-3476(98)70303-8

The Journal of Pediatrics
Volume 132, Issue 5 , Pages 777-782 , May 1998

Article Tools